Runtime
03:00
Intensive chemotherapy is one way of treating acute myeloid leukemia (AML), but many older adults have difficulty tolerating the side effects. Memorial Sloan-Kettering hematologist-oncologist Ellin Berman discusses a study that evaluates the safety and effectiveness of the investigational drug sapacitabine in patients age 70 and older who are newly diagnosed with AML.
Speaker(s)
Related Cancer & Treatment Information
See Videos Related to:
